Skip to main content
Top
Published in: Skeletal Radiology 9/2004

01-09-2004 | Article

Carbon-11-methionine positron emission tomography imaging of chordoma

Authors: Hong Zhang, Kyosan Yoshikawa, Katsumi Tamura, Kenji Sagou, Mei Tian, Tetsuya Suhara, Susumu Kandatsu, Kazutoshi Suzuki, Shuji Tanada, Hirohiko Tsujii

Published in: Skeletal Radiology | Issue 9/2004

Login to get access

Abstract

Objective

Chordoma is a rare malignant bone tumor that arises from notochord remnants. This is the first trial to investigate the utility of 11C-methionine (MET) positron emission tomography (PET) in the imaging of chordoma before and after carbon-ion radiotherapy (CIRT).

Design and patients

Fifteen patients with chordoma were investigated with MET-PET before and after CIRT and the findings analyzed visually and quantitatively. Tumor MET uptake was evaluated by tumor-to-nontumor ratio (T/N ratio).

Results

In 12 (80%) patients chordoma was clearly visible in the baseline MET-PET study with a mean T/N ratio of 3.3±1.7. The MET uptake decreased significantly to 2.3±1.4 after CIRT (P<0.05). A significant reduction in tumor MET uptake of 24% was observed after CIRT. Fourteen (93%) patients showed no local recurrence after CIRT with a median follow-up time of 20 months.

Conclusion

This study has demonstrated that MET-PET is feasible for imaging of chordoma. MET-PET could provide important tumor metabolic information for the therapeutic monitoring of chordoma after CIRT.
Literature
1.
go back to reference Baratti D, Gronchi A, Pennacchioli E, et al. Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Oncol 2003; 10:291-296.CrossRefPubMed Baratti D, Gronchi A, Pennacchioli E, et al. Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Oncol 2003; 10:291-296.CrossRefPubMed
2.
3.
go back to reference Breteau N, Demasure M, Lescrainier J, Sabbattier R, Michenet P. Sacrococcygeal chordomas: potential role of high LET therapy. Recent Results Cancer Res 1998; 150:148-155.PubMed Breteau N, Demasure M, Lescrainier J, Sabbattier R, Michenet P. Sacrococcygeal chordomas: potential role of high LET therapy. Recent Results Cancer Res 1998; 150:148-155.PubMed
4.
go back to reference Watkins L, Khudados ES, Kaleoglu M, Revesz T, Sacares P, Crockard HA. Skull base chordomas: a review of 38 patients, 1958–88. Br J Neurosurg 1993; 7:241-248.PubMed Watkins L, Khudados ES, Kaleoglu M, Revesz T, Sacares P, Crockard HA. Skull base chordomas: a review of 38 patients, 1958–88. Br J Neurosurg 1993; 7:241-248.PubMed
5.
go back to reference Gay E, Sekhar LN, Rubinstein E, et al. Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery 1995; 36:887-897.PubMed Gay E, Sekhar LN, Rubinstein E, et al. Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery 1995; 36:887-897.PubMed
6.
go back to reference Al-Mefty O, Borba LA. Skull base chordomas: a management challenge. J Neurosurg 1997; 86:182-189.PubMed Al-Mefty O, Borba LA. Skull base chordomas: a management challenge. J Neurosurg 1997; 86:182-189.PubMed
7.
go back to reference Krayenbuhl H, Yasargil MG. Cranial chordomas. Progr Neurol Surg 1975; 6:380–434. Krayenbuhl H, Yasargil MG. Cranial chordomas. Progr Neurol Surg 1975; 6:380–434.
8.
go back to reference Benk V, Liebsch NJ, Munzenrider JE, Efird J, McManus P, Suit H. Base of skull and cervical spine chordomas in children treated by high-dose irradiation. Int J Radiat Oncol Biol Phys 1995; 31:577–581.CrossRefPubMed Benk V, Liebsch NJ, Munzenrider JE, Efird J, McManus P, Suit H. Base of skull and cervical spine chordomas in children treated by high-dose irradiation. Int J Radiat Oncol Biol Phys 1995; 31:577–581.CrossRefPubMed
9.
go back to reference Castro JR, Collier JM, Petti PL, et al. Charged particle radiotherapy for lesions encircling the brain stem or spinal cord. Int J Radiat Oncol Biol Phys 1989; 17:477–484.PubMed Castro JR, Collier JM, Petti PL, et al. Charged particle radiotherapy for lesions encircling the brain stem or spinal cord. Int J Radiat Oncol Biol Phys 1989; 17:477–484.PubMed
10.
go back to reference Kamada T, Tsujii H, Tsuji H, et al. Working Group for the Bone and Soft Tissue Sarcomas. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol 2002; 20:4466–4471.CrossRefPubMed Kamada T, Tsujii H, Tsuji H, et al. Working Group for the Bone and Soft Tissue Sarcomas. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol 2002; 20:4466–4471.CrossRefPubMed
11.
go back to reference Gambhir SS. Molecular imaging of cancer with positron emission tomography. Natl Rev Cancer 2002; 2:683–693.CrossRef Gambhir SS. Molecular imaging of cancer with positron emission tomography. Natl Rev Cancer 2002; 2:683–693.CrossRef
12.
go back to reference Zhang H, Tian M, Oriuchi N, Higuch, T, Tanada S, Endo K. Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET. Br J Radiol 2002; 75:409–416.PubMed Zhang H, Tian M, Oriuchi N, Higuch, T, Tanada S, Endo K. Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET. Br J Radiol 2002; 75:409–416.PubMed
13.
go back to reference Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972―1980.PubMed Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972―1980.PubMed
14.
go back to reference Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991; 32:1485–1490.PubMed Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991; 32:1485–1490.PubMed
15.
go back to reference Hautzel H, Muller-Gartne, HW. Early changes in fluorine-18-FDG uptake during radiotherapy. J Nucl Med 1997; 38:1384–1386.PubMed Hautzel H, Muller-Gartne, HW. Early changes in fluorine-18-FDG uptake during radiotherapy. J Nucl Med 1997; 38:1384–1386.PubMed
16.
go back to reference Hoffman RM. Unbalanced transmethylation and the perturbation of the differentiated state leading to cancer. Bioessays 1990; 12:163–166.PubMed Hoffman RM. Unbalanced transmethylation and the perturbation of the differentiated state leading to cancer. Bioessays 1990; 12:163–166.PubMed
17.
go back to reference Kracht LW, Friese M, Herholz K, et al. Methyl-[11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging 2003; 30:868―873.PubMed Kracht LW, Friese M, Herholz K, et al. Methyl-[11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging 2003; 30:868―873.PubMed
18.
go back to reference Kubota R, Kubota K, Yamada S, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995; 36:484–492.PubMed Kubota R, Kubota K, Yamada S, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995; 36:484–492.PubMed
19.
go back to reference Schaider H, Haberkorn U, Berger MR, Oberdorfer F, Morr I, van Kaick G. Application of alpha-aminoiosbutyric acid,l-methionine, thymidine and 2-fluoro-2-d-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line. Eur J Nucl Med 1996; 23:55–60.PubMed Schaider H, Haberkorn U, Berger MR, Oberdorfer F, Morr I, van Kaick G. Application of alpha-aminoiosbutyric acid,l-methionine, thymidine and 2-fluoro-2-d-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line. Eur J Nucl Med 1996; 23:55–60.PubMed
20.
go back to reference Higashi K, Clavo AC, Wahl RL. In vitro assessment of 2-fluoro-2-d-glucose, l-methionine, thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. J Nucl Med 1993; 34:773–779.PubMed Higashi K, Clavo AC, Wahl RL. In vitro assessment of 2-fluoro-2-d-glucose, l-methionine, thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. J Nucl Med 1993; 34:773–779.PubMed
21.
go back to reference Kubota K, Ishiwata K, Kubota R, et al. Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine,l-[methyl-14C] methionine, [6-3H]thymidine, and gallium-67. J Nucl Med 1991; 32:2118–2123.PubMed Kubota K, Ishiwata K, Kubota R, et al. Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine,l-[methyl-14C] methionine, [6-3H]thymidine, and gallium-67. J Nucl Med 1991; 32:2118–2123.PubMed
22.
go back to reference Minn H, Clavo AC, Grenman R, Wahl RL. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose andl-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 1‘995; 36:252–258. Minn H, Clavo AC, Grenman R, Wahl RL. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose andl-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 1‘995; 36:252–258.
23.
go back to reference Stern PH, Hoffman RM. Elevated overall rates of transmethylation in cell lines from diverse human tumors. In Vitro 1984; 20:663–670.PubMed Stern PH, Hoffman RM. Elevated overall rates of transmethylation in cell lines from diverse human tumors. In Vitro 1984; 20:663–670.PubMed
24.
go back to reference Stern PH, Wallace CD, Hoffman RM. Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines. J Cell Physiol 1984; 119:29–34.PubMed Stern PH, Wallace CD, Hoffman RM. Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines. J Cell Physiol 1984; 119:29–34.PubMed
25.
go back to reference Wheatley DN. On the problem of linear incorporation of amino acids into cell protein. Experientia 1982; 38:818–820.PubMed Wheatley DN. On the problem of linear incorporation of amino acids into cell protein. Experientia 1982; 38:818–820.PubMed
26.
go back to reference Weiss SW. WHO international histological classification of tumours. Histological typing of soft tissue tumours, 2nd edn. Berlin Heidelberg New York: Springer, 1994. Weiss SW. WHO international histological classification of tumours. Histological typing of soft tissue tumours, 2nd edn. Berlin Heidelberg New York: Springer, 1994.
27.
go back to reference Langstrom B, Antoni G, Gullberg P, et al. Synthesis ofl-and d-[methy-11C]methionine. J Nucl Med 1987; 19:1037–1040. Langstrom B, Antoni G, Gullberg P, et al. Synthesis ofl-and d-[methy-11C]methionine. J Nucl Med 1987; 19:1037–1040.
28.
go back to reference Leskinen-Kallio S, Nagren K, Lehikoinen P, Ruotsalainen U, Joensuu H. Uptake of11C-methionine in breast cancer studied by PET. An association with the size of S-phase fraction. Br J Cancer 1991; 64:1121―1124.PubMed Leskinen-Kallio S, Nagren K, Lehikoinen P, Ruotsalainen U, Joensuu H. Uptake of11C-methionine in breast cancer studied by PET. An association with the size of S-phase fraction. Br J Cancer 1991; 64:1121―1124.PubMed
29.
go back to reference Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol 1999;175(Suppl 2):57–63. Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol 1999;175(Suppl 2):57–63.
30.
go back to reference Hug EB, Loredo LN, Slater JD, et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 1999; 91:432–439.PubMed Hug EB, Loredo LN, Slater JD, et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 1999; 91:432–439.PubMed
31.
go back to reference Verstraete KL, Lang P. Post-therapeutic magnetic resonance imaging of bone tumors. Top Magn Reson Imaging 1999; 10:237–246.PubMed Verstraete KL, Lang P. Post-therapeutic magnetic resonance imaging of bone tumors. Top Magn Reson Imaging 1999; 10:237–246.PubMed
32.
go back to reference Fletcher BD. Effects of pediatric cancer therapy on the musculoskeletal system. Pediatr Radiol 1997; 27:623–636.CrossRefPubMed Fletcher BD. Effects of pediatric cancer therapy on the musculoskeletal system. Pediatr Radiol 1997; 27:623–636.CrossRefPubMed
33.
go back to reference Murphy WA Jr. Imaging bone tumors in the 1990s. Cancer 1991; 67:1169–1176.PubMed Murphy WA Jr. Imaging bone tumors in the 1990s. Cancer 1991; 67:1169–1176.PubMed
34.
go back to reference Hawkins DS, Rajendran JG, Conrad EU 3rd, Bruckner JD, Eary JF. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-d-glucose positron emission tomography. Cancer 2002; 94:3277–3284.CrossRefPubMed Hawkins DS, Rajendran JG, Conrad EU 3rd, Bruckner JD, Eary JF. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-d-glucose positron emission tomography. Cancer 2002; 94:3277–3284.CrossRefPubMed
35.
go back to reference Findlay M, Young H, Cunningham D, et al. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. J Clin Oncol 1996; 14:700–708.PubMed Findlay M, Young H, Cunningham D, et al. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. J Clin Oncol 1996; 14:700–708.PubMed
36.
go back to reference Muhr C, Gudjonsson O, Lilja A, Hartman M, Zhang ZJ, Langstrom B. Meningioma treated with interferon-alpha, evaluated with [11C]-l-methionine positron emission tomography. Clin Cancer Res 2001; 7:2269―2276.PubMed Muhr C, Gudjonsson O, Lilja A, Hartman M, Zhang ZJ, Langstrom B. Meningioma treated with interferon-alpha, evaluated with [11C]-l-methionine positron emission tomography. Clin Cancer Res 2001; 7:2269―2276.PubMed
37.
go back to reference Andersson T, Wilander E, Eriksson B, Lindgren PG, Oberg K. Effects of interferon on tumor tissue content in liver metastases of human carcinoid tumors. Cancer Res 1990; 50:3413―3415.PubMed Andersson T, Wilander E, Eriksson B, Lindgren PG, Oberg K. Effects of interferon on tumor tissue content in liver metastases of human carcinoid tumors. Cancer Res 1990; 50:3413―3415.PubMed
Metadata
Title
Carbon-11-methionine positron emission tomography imaging of chordoma
Authors
Hong Zhang
Kyosan Yoshikawa
Katsumi Tamura
Kenji Sagou
Mei Tian
Tetsuya Suhara
Susumu Kandatsu
Kazutoshi Suzuki
Shuji Tanada
Hirohiko Tsujii
Publication date
01-09-2004
Publisher
Springer-Verlag
Published in
Skeletal Radiology / Issue 9/2004
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-004-0815-5

Other articles of this Issue 9/2004

Skeletal Radiology 9/2004 Go to the issue